Psoriasis and Cosmetic Surgery: Why Plaques Can Appear in a Fresh Incision, What to Do About Biologics and Methotrexate Before an Operation, How Scalp, Fold, and Nail Psoriasis Change a Facelift, Tummy Tuck, or Breast Reduction, and When Lasers and Peels Make Things Worse

The box on the intake form says "psoriasis," and the line underneath lists a drug with a name that ends in "mab." The patient is booked for a tummy tuck, or a facelift, or a breast reduction, and the conversation about the skin condition lasts about as long as it takes to write it down. Most of the time nothing goes wrong. Sometimes, three weeks after surgery, a patient looks at a healing incision and sees a thick, red, scaly line running exactly along the scar, and realizes that the condition everyone treated as a footnote has moved into the result.

Psoriasis is one of the most common chronic skin diseases in the United States. The National Psoriasis Foundation estimates that more than eight million Americans have it, and the American Academy of Dermatology describes it as an immune-mediated disease, not simply a rash: the immune system drives skin cells to grow and shed far faster than normal, producing the raised, scaly plaques most people recognize. It also reaches beyond the skin. A substantial share of patients develop psoriatic arthritis, and psoriasis is linked in large studies with obesity, diabetes, high blood pressure, fatty liver disease, cardiovascular disease, and depression. Each of those has something to say about elective surgery.

This piece explains why injured skin can grow new plaques and what that means for incisions, lasers, peels, and tattoos, how the medications that control psoriasis are handled around an operation, how the location of the disease changes specific procedures, and how to time surgery around a condition that waxes and wanes. It is general information. The decisions about medications belong to the patient's dermatologist or rheumatologist and the surgeon together, and they depend on the individual drug, the individual operation, and the individual patient.

What psoriasis is, and why a cosmetic surgeon should care about more than the skin

The short answer: psoriasis is a chronic immune-mediated disease that shows up mainly as scaly plaques but is associated with joint disease and with metabolic and cardiovascular conditions, so a surgeon should know its type, its extent, how active it is, what treats it, and what comes with it before scheduling an elective operation.

Most people with psoriasis have plaque psoriasis: well-defined, raised, red or violet patches covered in silvery or grayish scale, commonly on the elbows, knees, scalp, and lower back. On deeper skin tones the plaques may look purple, brown, or gray, and the redness that clinicians are taught to look for can be subtle, a theme the piece on cosmetic procedures on deeper skin tones covers more broadly. Other forms matter for surgical planning:

• Inverse psoriasis. Smooth, shiny, red patches without much scale in skin folds: under the breasts, in the belly fold, the groin, the armpits, and between the buttocks. These are the same creases that a tummy tuck, breast reduction, or thigh lift incision often sits in.
• Scalp psoriasis. Thick scale on the scalp, often spilling past the hairline onto the forehead and behind the ears, which is where facelift and brow lift incisions are hidden.
• Nail psoriasis. Pitting, thickening, separation of the nail from the bed, and discoloration. It is more common in people with psoriatic arthritis and can interfere with something as ordinary as a finger pulse oximeter.
• Guttate psoriasis. Many small, drop-shaped spots, often triggered by a strep throat infection, that can appear suddenly.
• Pustular and erythrodermic psoriasis. Uncommon, severe forms with widespread pustules or redness covering most of the body. These are medical problems, sometimes emergencies, and a reason to postpone elective surgery without discussion.

Psoriatic arthritis affects a meaningful minority of people with psoriasis; the National Psoriasis Foundation commonly cites roughly one in three. It can cause swollen fingers and toes, stiff joints, back pain, and fatigue. The associations with metabolic disease are the other half of the story. Dermatology and cardiology literature has repeatedly found higher rates of obesity, insulin resistance, high cholesterol, and high blood pressure in people with moderate to severe psoriasis, and the joint guidelines published by the American Academy of Dermatology and the National Psoriasis Foundation recommend screening for those conditions. A patient with significant psoriasis who arrives for body contouring is therefore more likely than average to have the risk factors the piece on high blood pressure before cosmetic surgery and the piece on fatty liver disease and cosmetic surgery describe. Smoking and heavy drinking are both linked to worse psoriasis, too, and the piece on smoking cessation timelines applies with extra force.

Psoriasis also shares the planning problems of other immune-mediated diseases, which the piece on cosmetic surgery with autoimmune disease lays out in general terms. What is distinctive about psoriasis is how directly the skin itself responds to surgery.

The Koebner phenomenon: new plaques in incisions, laser zones, tattoos, and garment lines

The short answer: in a share of people with psoriasis, injury to normal-looking skin can trigger a new plaque at the injury site, usually within days to a few weeks, which means incisions, laser and peel treatments, tattoos, and even friction from tape and compression garments can produce psoriasis exactly where the cosmetic result is supposed to be.

The German dermatologist Heinrich Koebner described the phenomenon in the 1870s, after noticing psoriasis appearing in scratches, horse bites, and tattoos on his patients. It is now known to occur in several skin diseases, including vitiligo and lichen planus, as the piece on vitiligo and the Koebner effect explains. In psoriasis, estimates of how many patients experience it vary widely between studies, with figures around a quarter often cited and some series reporting more. The new plaque typically appears one to three weeks after the injury, though longer gaps have been reported. It is more likely when the disease is active and spreading than when it is quiet.

What counts as injury is broad. In the cosmetic setting, the list includes:

• Surgical incisions. A plaque can form along the length of a scar, which turns a fine line into a raised, scaly stripe. It usually responds to treatment, but it can delay the time when the scar settles and makes scar assessment harder. The piece on scar care after plastic surgery describes the usual timeline that psoriasis can interrupt.
• Lasers, peels, and microneedling. Ablative laser resurfacing and medium or deep peels injure the whole treated surface, which is the point of those treatments and the reason they are a particular risk in active psoriasis. Paradoxically, a specific narrow-band excimer laser at 308 nanometers is used by dermatologists to treat psoriasis plaques, which is a reminder that the device and the setting matter. Cosmetic resurfacing, compared in the piece on ablative versus non-ablative laser resurfacing, is a different operation altogether.
• Tattooing and cosmetic pigment. Microblading, lip blush, areola tattooing after breast surgery, and scar camouflage can all koebnerize. The piece on scar camouflage and medical tattooing explains why any pigment work on altered skin should wait for quiet disease.
• Friction, tape, and pressure. Adhesive dressings, the repeated stripping of tape, and the seams and edges of compression garments are low-grade injuries, and psoriasis can follow them. The piece on adhesive and tape rash after cosmetic surgery and the piece on waist trainers and fajas after liposuction describe the garden-variety skin problems that a patient with psoriasis may experience in a stronger form.
• Sunburn. A sunburned forehead or chest after surgery is another form of injury, and it can trigger plaques as well as pigment problems.

None of this is a reason to refuse surgery to people with psoriasis. It is a reason to operate when the disease is controlled, to avoid incising through active plaques where an alternative exists, to tell the patient in advance what a koebnerized scar looks like, and to arrange quick access to the dermatologist if one appears. Early treatment with topical medication usually flattens the plaque. Leaving it alone while everyone wonders whether it is an infection or a reaction to the stitches wastes weeks.

"

In psoriasis, an incision is not only a cut that has to heal. It is an injury the disease may decide to occupy, and the time to plan for that is before the first stroke of the scalpel, not three weeks later at the follow-up visit.

"

Biologics, methotrexate, and the other drugs: what happens to them around surgery

The short answer: there is no single rule, but the common approach is to keep the disease controlled rather than stop everything, to time the operation within the dosing cycle of a biologic when a pause is chosen, to continue methotrexate in many cases, to handle cyclosporine, acitretin, and systemic steroids with particular care, and to make every one of those decisions together with the prescribing doctor.

Psoriasis treatment has changed dramatically in two decades. A patient may be using nothing but creams, or a systemic drug that reshapes the immune response. The main categories, and the surgical questions each raises, look like this:

Topical treatments. Corticosteroid creams, vitamin D analogs such as calcipotriene, topical tapinarof and roflumilast, and coal tar products are generally continued until shortly before surgery and avoided on the incision until it has healed. Long-term strong steroid use on the face thins the skin, a problem described in the piece on perioral dermatitis and steroid creams, and thinned skin at a planned incision site is worth noting.

Phototherapy. Narrow-band ultraviolet B treatment, given in a dermatologist's office several times a week, is a common middle step. It tans the skin and can change how laser treatments behave, and patients usually pause it around surgery and while incisions heal.

Methotrexate. The oldest widely used systemic drug for psoriasis, taken once a week. In rheumatology, where most of the surgical data come from, the American College of Rheumatology's perioperative guidance for patients having elective hip and knee replacement recommends continuing methotrexate through surgery, because studies have not shown a meaningful increase in infection and stopping it risks a flare. Plastic surgeons often extrapolate from that guidance, though a facelift and a joint replacement are not the same operation. Methotrexate also affects the liver and blood counts, and recent labs are a reasonable request.

Cyclosporine. A powerful but older drug used for short courses in severe flares. It raises blood pressure, can impair kidney function, and is more strongly immunosuppressive. Most surgeons prefer not to schedule elective cosmetic surgery while a patient is on it.

Acitretin. An oral retinoid used for some forms of psoriasis. It can cause birth defects, and its label requires that women avoid pregnancy for three years after stopping it, which matters for any patient who is combining body contouring with future family plans. Retinoids have also been associated with slower or unpredictable healing after aggressive resurfacing, so surgeons and dermatologists often want a gap between acitretin and resurfacing or significant surgery; the specific interval is a judgment call.

Apremilast and deucravacitinib. Two oral drugs that act on immune signaling pathways in a more targeted way. They are not thought to carry the same infection risk as the broad immunosuppressants, and they are often continued or briefly held depending on the prescriber's preference.

Biologics. Injectable or infused antibodies that block specific immune signals. They include the TNF inhibitors (adalimumab, etanercept, infliximab, certolizumab), the IL-17 inhibitors (secukinumab, ixekizumab, brodalumab, bimekizumab), the IL-23 inhibitors (guselkumab, risankizumab, tildrakizumab), and ustekinumab, which blocks IL-12 and IL-23. The concern with surgery is a modest increase in infection risk, and the concern with stopping them is a flare, sometimes a significant one, plus in some cases a reduced response when the drug is restarted. The American Academy of Dermatology and National Psoriasis Foundation biologic guidelines treat the question in terms of surgical risk: continuation is often reasonable for low-risk procedures, and larger operations call for an individual decision. The rheumatology guidance for joint replacement suggests that when a biologic is held, the surgery is scheduled near the end of a dosing interval, so the drug level is at its lowest, and the drug is restarted once the wound is healing well and there is no sign of infection. The intervals differ widely between drugs, from weekly injections to doses every twelve weeks, which is why a blanket rule such as "stop two weeks before" makes little sense. The piece on hidradenitis suppurativa and biologics covers the same questions for another skin disease treated with several of the same drugs.

Systemic steroids. This category deserves its own warning. Oral or injected corticosteroids are generally avoided in psoriasis because stopping them can trigger a rebound flare, occasionally into the pustular form. Some surgeons prescribe a short steroid course for swelling after facial surgery, a practice discussed in the piece on steroids for swelling after plastic surgery. For a patient with psoriasis, that prescription should be a conscious decision, not a routine order. A few other common drugs, including lithium, some beta-blockers, and the antimalarial hydroxychloroquine, have been reported to worsen psoriasis in some patients and are worth flagging on the medication list.

Infection prevention follows from all of this. Psoriatic plaques carry more bacteria on their surface than normal skin, especially Staphylococcus aureus, and orthopedic studies have reported higher wound complication rates when incisions pass through active plaques, though not every study agrees. Surgeons commonly ask that plaques near the operative field be treated into remission beforehand, and they plan incisions to avoid active disease when possible. Routine extended antibiotics are not automatically warranted; the reasoning in the piece on antibiotics after cosmetic surgery still applies. And because supplements marketed for psoriasis (fish oil, turmeric, and others) appear on the supplements stop list for their effects on bleeding, they belong on the medication form too.

Where the disease lives: scalp, folds, nails, and joints in specific procedures

The short answer: the location of a patient's psoriasis changes the details of specific operations, because scalp disease sits on facelift and brow lift incisions, inverse psoriasis lives in the creases where tummy tuck and breast reduction scars go, nail disease affects monitoring and hand procedures, and psoriatic arthritis affects positioning, recovery, and what a patient can physically manage at home.

Scalp psoriasis and facial surgery. Facelift, brow lift, and hairline incisions run through or along the scalp, in front of and behind the ear, and along the back hairline, exactly where scalp psoriasis tends to sit. Active scale on the scalp makes the incision harder to clean and close and gives the Koebner phenomenon an obvious target. Most surgeons want scalp disease controlled for some weeks before a facelift; treatment shampoos and scalp solutions can then be resumed once the incisions have healed, often on the surgeon's schedule for the first hair wash. The piece on hair dye and hair washing after a facelift describes those timelines, and patients with psoriasis may need to wait slightly longer for medicated products and dyes. Ear and retroauricular psoriasis, which can be mistaken for dandruff or eczema, matters for the incision around the ear that the piece on the deep plane facelift describes. Eyelid procedures rarely involve plaques directly, but the face is a common place for thinning from years of topical steroids.

Inverse psoriasis and body contouring. Psoriasis in the belly fold, under the breasts, and in the groin is moist, often colonized by yeast and bacteria, and slow to respond to treatment. A panniculectomy or tummy tuck and a breast reduction both put long incisions near those creases. There is a reasonable argument that removing a heavy apron of skin or reducing heavy breasts can improve fold psoriasis afterward, by eliminating the moist skin-on-skin contact that keeps it going, and some patients do report that. The evidence is anecdotal rather than systematic, and surgery should not be sold as a treatment for psoriasis. What is clear is that active disease in the fold should be calmed beforehand, that the incision should be kept dry and well supported, and that the risk of separation along the incision, described in the piece on wound dehiscence, is higher when the skin around it is inflamed.

Nail psoriasis and the day of surgery. Thickened or lifted nails can make finger pulse oximeters read poorly, and many surgical centers ask patients to remove nail polish for the same reason, as the piece on day-of-surgery rules explains. Telling the anesthesia team about nail disease lets them choose another finger, a toe, or an ear or forehead sensor.

Psoriatic arthritis and recovery. Stiff, painful joints matter for positioning on the operating table, for lifting and moving during recovery, and for tasks such as fastening a compression garment or emptying a drain. Neck stiffness, which can occur in the spinal form of the disease, is worth mentioning to the anesthesiologist. Hand rejuvenation with filler or fat, covered in the piece on hand rejuvenation, should avoid inflamed joints, and swelling in a finger from dactylitis is not something filler can or should disguise. Anti-inflammatory painkillers that a patient relies on for joint pain may need to be adjusted around surgery for their bleeding effects, which is a decision for the surgeon and the rheumatologist rather than a reason to suffer through recovery.

Injectables. Neurotoxin and filler injections are small injuries, and a few case reports describe psoriasis at injection sites. In practice, injectables are widely given to people with psoriasis without trouble. Patients on biologics should mention them to the injector, and injections should avoid active plaques.

Timing, weight, mood, and who should be on the team

The short answer: the right time for elective cosmetic surgery is when the psoriasis has been controlled for a period of months on a stable regimen, after any planned weight change, and with the dermatologist (or rheumatologist) and surgeon working from the same plan, rather than at the convenience of a booking calendar or in the middle of a flare.

Operate on quiet skin. Psoriasis fluctuates. Infections, stress, cold dry weather, alcohol, and some drugs can set off flares, and so can surgery itself in some patients. The Koebner phenomenon is more likely during active, spreading disease. The practical rule is to schedule elective surgery after a period of stable control, not in the weeks after starting a new drug or while a flare is still settling. A patient who has just switched biologics because the old one stopped working is usually better off waiting until the new one has proved itself.

Weight and GLP-1 drugs. Weight loss tends to improve psoriasis, and a growing literature describes better skin in people with obesity who lose weight, including with GLP-1 medications. That is good news, but it adds a reason to finish the weight change first. Body contouring done before weight stabilizes produces results that change, as the piece on GLP-1 drugs before plastic surgery explains, and the medication changes in that piece (including stopping the injections before anesthesia) interact with any psoriasis drug adjustments.

Mood and expectations. Psoriasis is associated with higher rates of depression and anxiety, and many patients have spent years hiding their skin. Cosmetic surgery can be a meaningful lift for people who have felt self-conscious about their bodies, and it can also become a focus for distress that is really about the disease. The piece on body dysmorphic disorder screening explains why a careful practice asks about this. A patient whose real wish is clearer skin needs a dermatologist more than a surgeon, and modern psoriasis treatment can produce dramatic clearing.

Who should be involved. The dermatologist who manages the psoriasis, and the rheumatologist if there is psoriatic arthritis, should approve the medication plan in writing. The surgeon should be certified by the American Board of Plastic Surgery or, for facial work, the American Board of Facial Plastic and Reconstructive Surgery, as the piece on board certifications explains, and should be comfortable coordinating rather than improvising. The anesthesia team needs to know about biologics, steroids, nail disease, and neck stiffness. Patients who get a dismissive answer about any of this can seek a second consultation, and those planning staged procedures should budget for the possibility that a flare delays one of them, a point the piece on what a surgical quote covers helps frame.

The honest summary

Psoriasis is common, and people who have it undergo cosmetic surgery safely every day. It is still not a footnote. It is an immune-mediated disease that can produce new plaques in injured skin, travels with joint disease and metabolic conditions, and is controlled by drugs that matter around an operation.

The Koebner phenomenon is the most visible risk. In a share of patients, an incision, a laser treatment, a peel, a tattoo, or the friction of tape and garments can produce psoriasis along the injury, usually within a few weeks. It is more likely when the disease is active, it usually responds to prompt treatment, and the way to minimize it is to operate on quiet skin, avoid cutting through active plaques, and arrange quick dermatology follow-up.

The medications require a plan rather than a reflex. Methotrexate is commonly continued, cyclosporine is generally a reason to wait, acitretin raises pregnancy and healing questions, and biologics are often either continued for small procedures or briefly held with the operation timed to the end of a dosing interval for larger ones. Oral steroids, sometimes prescribed casually after facial surgery, can trigger a rebound flare in psoriasis and should be a deliberate decision.

Location shapes the details. Scalp disease sits on facelift incisions, inverse psoriasis sits in the folds where tummy tuck and breast reduction scars go, nail disease affects monitoring, and psoriatic arthritis affects recovery. The patient who arrives with controlled disease, a written medication plan agreed with the dermatologist, and a surgeon who has asked where the plaques usually appear is in a very different position from the patient whose diagnosis was written on a form and never mentioned again.